 San Francisco, California--Newsfile Corp. - October 29, 2020 - Hagens Berman urges Homology Medicines, Inc. NASDAQ: FIXX investors with significant losses to submit your losses now. The firm is investigating possible securities fraud and certain investors may have valuable claims.Relevant Period: Before July 21, 2020Visit: An Attorney Now: Medicines, Inc. FIXX Investigation:Homology Medicines is a Boston, MA-based gene therapy company focused on curing rare geneti 